Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Understanding CYP2C9 and Phase 1 Detoxification

Phase 1 detoxification is the liver's first step in breaking down toxins so the body can remove them. The CYP2C9 gene encodes an important enzyme in this pathway. This enzyme helps metabolize a range of environmental and food-related substances, including cannabinoids such as THC, chemicals from plastics and cosmetics, compounds formed in well-done meats, food dyes, and mycotoxins from molds. Variations in CYP2C9 can change how quickly or efficiently these substances are processed.

Why this matters for your health

If CYP2C9 activity is reduced, substances that normally get processed in Phase 1 may linger longer or be handled less efficiently. That can affect how your body responds to everyday chemical exposures and some medications. Regardless of genotype, lifestyle choices and nutrition play a major role in supporting detox pathways and overall liver health.

Genetic Interpretations

2 effect alleles (TT) — Reduced CYP2C9 activity

Having the TT genotype for rs1799853 means you carry two copies of the effect allele associated with reduced CYP2C9 enzyme activity. This can lead to decreased Phase 1 detox capacity for substances normally processed by CYP2C9, including:

  • THC and other compounds found in cannabis
  • Phthalates and other plasticizers
  • Parabens and preservatives in cosmetics
  • Heterocyclic amines in well-done meats
  • Ochratoxin and other mold-related mycotoxins

Potential implications:

  • Slower metabolism of certain environmental chemicals and some medications
  • Greater sensitivity to cumulative chemical exposure
  • Increased importance of supporting other detox pathways and elimination
1 effect allele (CT) — Slightly reduced CYP2C9 activity

Having the CT genotype means you carry one copy of the effect allele and one non-effect allele. This is associated with a modest reduction in CYP2C9 activity compared to typical function. You likely process CYP2C9 substrates somewhat more slowly than individuals with two non-effect alleles, but not as slowly as those with two effect alleles.

Key considerations:

  • Be mindful of cumulative exposures to chemicals metabolized by CYP2C9
  • Support Phase 1 and downstream detoxification through diet and lifestyle
  • Discuss medication metabolism with your healthcare provider when starting new prescriptions
0 effect alleles (CC) — Typical CYP2C9 activity

Having the CC genotype indicates two copies of the non-effect allele and typical CYP2C9 enzyme activity. Your Phase 1 detoxification capacity for CYP2C9 substrates is expected to be within the standard range.

What this means:

  • Your liver should process CYP2C9-metabolized substances efficiently under normal conditions
  • Maintaining healthy habits will help preserve this function as you age
  • Continued attention to exposures and medication interactions is still important

Practical Recommendations to Support Detoxification

PlexusDx provides genetic information to help you understand potential predispositions. This is educational only and not medical advice. Always consult your healthcare provider before making medical decisions or starting new supplements or major lifestyle changes.

Dietary guidelines

  • Eat a diverse, colorful diet rich in fruits and vegetables to provide antioxidants and phytonutrients that support both Phase 1 and Phase 2 detoxification.
  • Include cruciferous vegetables such as broccoli, cauliflower, and Brussels sprouts to support liver enzyme activity and promote balanced detox pathways.
  • Choose lean protein sources and limit consumption of well-done and charred meats to reduce exposure to heterocyclic amines.
  • Favor whole grains, legumes, nuts, and seeds for fiber to support gut health and elimination of toxins.
  • Minimize processed foods and artificial dyes which can add to the detox burden.

Targeted nutrients and supplements

  • Zinc and iron: support enzyme function and overall metabolic health. Ensure intake is appropriate for your needs; excess iron can be harmful.
  • Curcumin (from turmeric): has supportive properties for liver function and inflammation. Use a formulation with good absorption if supplementing.
  • Support Phase 2 pathways with adequate sulfur-containing foods such as garlic, onions, eggs, and cruciferous vegetables, which assist conjugation and elimination.
  • Consider a high-quality multivitamin if dietary intake is limited, after discussion with your provider.

Lifestyle strategies

  • Reduce exposures: opt for fragrance-free and paraben-free personal-care products, minimize use of plastics for food storage, and choose organic produce when feasible to lower pesticide intake.
  • Hydration: adequate water intake supports kidney function and removal of water-soluble metabolites.
  • Regular exercise: physical activity improves circulation, supports lymphatic flow, and boosts metabolic health.
  • Sleep: aim for consistent, restorative sleep to allow the body time to repair and support detox pathways.
  • Avoid unnecessary chemical exposures: limit smoking, reduce indoor mold exposure, and be cautious with recreational drug use that relies on CYP2C9 metabolism.

Monitoring and tests to consider

  • Discuss liver function tests with your healthcare provider if you have concerns about exposure or symptoms affecting liver health.
  • Medication review: share your CYP2C9 results with your clinician or pharmacist to evaluate potential drug metabolism considerations for medications processed by CYP2C9.
  • Environmental exposure assessment: if you suspect high exposure to molds, plastics, or pesticides, your clinician may recommend targeted testing or remediation strategies.

How to use this information

Use your CYP2C9 genotype as one piece of a bigger health picture. Genetics can suggest tendencies but do not determine outcomes. Lifestyle, diet, environment, and medical care all shape how your detoxification systems perform. If your genotype indicates reduced CYP2C9 activity, focusing on exposure reduction and supporting nutrition and elimination pathways can help compensate. If your genotype indicates typical activity, maintaining healthy habits will protect that function over time.

When to contact a healthcare provider

  • Before starting or stopping prescription medications, especially those metabolized by CYP2C9
  • If you have symptoms of liver dysfunction such as jaundice, dark urine, persistent fatigue, or unexplained abdominal pain
  • If you are considering high-dose supplements or complex detox regimens

PlexusDx does not provide medical advice. This information is intended to educate about genetic predispositions. Always consult your healthcare provider for personalized medical guidance and before making changes to your health regimen.

If this genetic variant is present in your PlexusDx results, the following tests and reports are commonly used to explore it further:

🧬 Genetic Tests:

🧪 Blood Tests:

📄 Genetic Report:

Frequently Asked Questions About PHASE 1 DETOX and CYP2C9 rs1799853

How does the CYP2C9 gene affect Phase 1 detoxification?

CYP2C9 encodes an enzyme that helps the liver carry out Phase 1 detoxification by metabolizing a variety of substances, including cannabinoids (like THC), chemicals found in plastics and cosmetics (such as phthalates and parabens), compounds from well-done meats (heterocyclic amines), food dyes, and mold-derived mycotoxins. Genetic variations in CYP2C9 can influence how quickly or efficiently these substances are processed.

What do CYP2C9 rs1799853 genotypes (CC, CT, TT) mean for detox capacity?

For rs1799853, CC is associated with typical CYP2C9 enzyme activity, CT is associated with a modest reduction in activity, and TT (two effect alleles) is associated with reduced CYP2C9 activity. With reduced activity (especially TT), Phase 1 detox capacity for CYP2C9-metabolized substances may be lower, which can increase sensitivity to cumulative chemical exposure and may affect how certain medications are processed.

What lifestyle and nutrition steps can support detoxification if CYP2C9 activity is reduced?

If your genotype suggests reduced CYP2C9 activity, focus on lowering exposure to chemicals (choose fragrance-free/paraben-free products, reduce plastic exposure for food storage, minimize mold exposure, and be cautious with recreational substances), and support detox through diet and routine. Helpful steps include eating a diverse, colorful diet rich in fruits and vegetables, including cruciferous vegetables, choosing lean proteins and limiting well-done/charred meats, prioritizing fiber for elimination, staying hydrated, exercising regularly, and maintaining consistent sleep. Discuss medication metabolism with a healthcare provider when starting new prescriptions, and consider liver function tests or exposure-focused evaluation if you have concerns or symptoms.

What tests can help me learn more about PHASE 1 DETOX and CYP2C9 rs1799853?

The Functional Health Genetic Test delivers over 750 personalized genetic insights across 10 in-depth genetic reports to support whole-body, systems-level health understanding. The Detoxification Genetic Report translates your results into personalized, actionable guidance. Your healthcare provider can also recommend targeted blood tests based on your specific pathway results and health history to complement your genetic insights with current biomarker data.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.